Via Natta, Italy

Carmine D'urzo

This inventor holds 1 USPTO granted patent. Top assignee: Italfarmaco Spa. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carmine D'urzo. Retrieved from https://idiyas.com/inventor/carmine-d-urzo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carmine D’Urzo: Inventor in Pharmaceutical Treatment

Introduction

Carmine D’Urzo is an inventor associated with Via Natta, Italy, and Italfarmaco S.p.A. His patent work concerns a pharmaceutical approach to treating Philadelphia-negative myeloproliferative syndromes.

Latest Patents

D’Urzo is credited with 1 patent: “Method for treating Philadelphia-negative myeloproliferative syndromes.” The patent describes administering diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride, or a pharmaceutically acceptable salt or solvate, in combination with hydroxyurea to a patient requiring treatment.

Career Highlights

His listed invention focuses on combining pharmaceutical compounds as a treatment method for a specific group of blood disorders. The available information identifies Italfarmaco S.p.A. as the company with which he is associated.

Collaborations

Carmine D’Urzo’s listed coworkers include Paolo Mascagni and José Golay.

Conclusion

Carmine D’Urzo’s patent record highlights his contribution to pharmaceutical treatment research through an invention addressing Philadelphia-negative myeloproliferative syndromes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…